Iodine Maps from Dual-Energy CT to Predict Extrathyroidal Extension and Recurrence in Papillary Thyroid Cancer Based on a Radiomics Approach

References

1. 1.↵
   1. Haugen BR,
   2. Alexander EK,
   3. Bible KC, et al

   . 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133 doi:10.1089/thy.2015.0020 pmid:26462967

   CrossRefPubMed
2. 2.↵
   1. Liu G,
   2. Liu Q,
   3. Sun SR

   . Nomograms for estimating survival in patients with papillary thyroid cancer after surgery. Cancer Manag Res 2019;11:3535–44 doi:10.2147/CMAR.S194366 pmid:31114382

   CrossRefPubMed
3. 3.↵
   1. Youngwirth LM,
   2. Adam MA,
   3. Scheri RP, et al

   . Extrathyroidal extension is associated with compromised survival in patients with thyroid cancer. Thyroid 2017;27:626–31 doi:10.1089/thy.2016.0132 pmid:27597378

   CrossRefPubMed
4. 4.↵
   1. Kuo EJ,
   2. Thi WJ,
   3. Zheng F, et al

   . Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension. Thyroid 2017;27:1544–49 doi:10.1089/thy.2017.0457 pmid:29113553

   CrossRefPubMed
5. 5.↵
   1. Lee DY,
   2. Kwon TK,
   3. Sung MW, et al

   . Prediction of extrathyroidal extension using ultrasonography and computed tomography. Int J Endocrinol 2014;2014:351058 doi:10.1155/2014/351058 pmid:25525431

   CrossRefPubMed
6. 6.↵
   1. Seo YL,
   2. Yoon DY,
   3. Lim KJ, et al

   . Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? AJR Am J Roentgenol 2010;195:W240–44 doi:10.2214/AJR.09.3965 pmid:20729422

   CrossRefPubMed
7. 7.↵
   1. Kim WY,
   2. Kim HY,
   3. Son GS, et al

   . Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. J Can Res Ther 2014;10:50–55 doi:10.4103/0973-1482.131366 pmid:24762486

   CrossRefPubMed
8. 8.↵
   1. Kim SS,
   2. Lee BJ,
   3. Lee JC, et al

   . Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 2011;33:1719–26 doi:10.1002/hed.21658 pmid:22076977

   CrossRefPubMed
9. 9.↵
   1. Zhou M,
   2. Scott J,
   3. Chaudhury B, et al

   . Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. AJNR Am J Neuroradiol 2018;39:208–16 doi:10.3174/ajnr.A5391 pmid:28982791

   Abstract/FREE Full Text
10. 10.↵
    1. O’Connor JP,
    2. Rose CJ,
    3. Waterton JC, et al

    . Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 2015;21:249–57 doi:10.1158/1078-0432.CCR-14-0990 pmid:25421725

    Abstract/FREE Full Text
11. 11.↵
    1. Wang H,
    2. Song B,
    3. Ye N, et al

    . Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma. Eur J Radiol 2020;122:108755 doi:10.1016/j.ejrad.2019.108755 pmid:31783344

    CrossRefPubMed
12. 12.↵
    1. Kwon MR,
    2. Shin JH,
    3. Park H, et al

    . Radiomics study of thyroid ultrasound for predicting BRAF mutation in papillary thyroid carcinoma: preliminary results. AJNR Am J Neuroradiol 2020;41:700–05 doi:10.3174/ajnr.A6505 pmid:32273326

    Abstract/FREE Full Text
13. 13.↵
    1. Patel NU,
    2. Lind KE,
    3. McKinney K, et al

    . Clinical validation of a predictive model for the presence of cervical lymph node metastasis in papillary thyroid cancer. AJNR Am J Neuroradiol 2018;39:756–61 doi:10.3174/ajnr.A5554 pmid:29449283

    Abstract/FREE Full Text
14. 14.↵
    1. Yu J,
    2. Deng Y,
    3. Liu T, et al

    . Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun 2020;11:4807 doi:10.1038/s41467-020-18497-3 pmid:32968067

    CrossRefPubMed
15. 15.↵
    1. Chen B,
    2. Zhong L,
    3. Dong D, et al

    . Computed tomography radiomic nomogram for preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma. Front Oncol 2019;9:829 doi:10.3389/fonc.2019.00829 pmid:31555589

    CrossRefPubMed
16. 16.↵
    1. McCollough CH,
    2. Leng S,
    3. Yu L, et al

    . Dual- and multi-energy CT: principles, technical approaches, and clinical applications. Radiology 2015;276:637–53 doi:10.1148/radiol.2015142631 pmid:26302388

    CrossRefPubMed
17. 17.↵
    1. Agrawal MD,
    2. Pinho DF,
    3. Kulkarni NM, et al

    . Oncologic applications of dual-energy CT in the abdomen. Radiographics 2014;34:589–612 doi:10.1148/rg.343135041 pmid:24819783

    CrossRefPubMed
18. 18.↵
    1. Li M,
    2. Zheng X,
    3. Li J, et al

    . Dual-energy computed tomography imaging of thyroid nodule specimens: comparison with pathologic findings. Invest Radiol 2012;47:58–64 doi:10.1097/RLI.0b013e318229fef3 pmid:21788907

    CrossRefPubMed
19. 19.↵
    1. Gao SY,
    2. Zhang XY,
    3. Wei W, et al

    . Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: a retrospective diagnostic accuracy study. Medicine (Baltimore) 2016;95:e4816 doi:10.1097/MD.0000000000004816 pmid:27684811

    CrossRefPubMed
20. 20.↵
    1. Liu X,
    2. Ouyang D,
    3. Li H, et al

    . Papillary thyroid cancer: dual-energy spectral CT quantitative parameters for preoperative diagnosis of metastasis to the cervical lymph nodes. Radiology 2015;275:167–76 doi:10.1148/radiol.14140481 pmid:25521777

    CrossRefPubMed
21. 21.↵
    1. Choe J,
    2. Lee SM,
    3. Do KH, et al

    . Prognostic value of radiomic analysis of iodine overlay maps from dual-energy computed tomography in patients with resectable lung cancer. Eur Radiol 2019;29:915–23 doi:10.1007/s00330-018-5639-0 pmid:30054795

    CrossRefPubMed
22. 22.↵
    1. Zhou Y,
    2. Su GY,
    3. Hu H, et al

    . Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer. Eur Radiol 2020;30:6251–62 doi:10.1007/s00330-020-06866-x pmid:32500193

    CrossRefPubMed
23. 23.↵
    1. Zhou Y,
    2. Su GY,
    3. Hu H, et al

    . Radiomics from primary tumor on dual-energy CT derived iodine maps can predict cervical lymph node metastasis in papillary thyroid cancer. Acad Radiol 2022;29(Suppl 3):S222–31 doi:10.1016/j.acra.2021.06.014 pmid:34366279

    CrossRefPubMed
24. 24.↵
    1. Kim SY,
    2. Kwak JY,
    3. Kim EK, et al

    . Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma. Radiology 2015;277:574–83 doi:10.1148/radiol.2015142470 pmid:25955580

    CrossRefPubMed
25. 25.↵
    1. Park JE,
    2. Lee JH,
    3. Ryu KH, et al

    . Improved diagnostic accuracy using arterial phase CT for lateral cervical lymph node metastasis from papillary thyroid cancer. AJNR Am J Neuroradiol 2017;38:782–88 doi:10.3174/ajnr.A5054 pmid:28126748

    Abstract/FREE Full Text
26. 26.↵
    1. Wels MG,
    2. Lades F,
    3. Muehlberg A, et al

    . General purpose radiomics for multi-modal clinical research. In: Proceedings of SPIE Medical Imaging, San Diego, California. March 13, 2019 doi:10.1117/12.2511856

    CrossRef
27. 27.↵
    1. Moltz JH,
    2. Bornemann L,
    3. Kuhnigk JM, et al

    . Advanced segmentation techniques for lung nodules, liver metastases, and enlarged lymph nodes in CT scans. IEEE J Sel Top Signal Process 2009;3:122–34 doi:10.1109/JSTSP.2008.2011107

    CrossRef
28. 28.↵
    1. van Griethuysen JJM,
    2. Fedorov A,
    3. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104–07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    Abstract/FREE Full Text
29. 29.↵
    1. Kramer AA,
    2. Zimmerman JE

    . Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med 2007;35:2052–56 doi:10.1097/01.CCM.0000275267.64078.B0 pmid:17568333

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Fitzgerald M,
    2. Saville BR,
    3. Lewis RJ

    . Decision curve analysis. JAMA 2015;313:409–10 doi:10.1001/jama.2015.37 pmid:25626037

    CrossRefPubMed
31. 31.↵
    1. Rajabi S,
    2. Dehghan MH,
    3. Dastmalchi R, et al

    . The roles and role-players in thyroid cancer angiogenesis. Endocr J 2019;66:277–93 doi:10.1507/endocrj.EJ18-0537 pmid:30842365

    CrossRefPubMed
32. 32.↵
    1. Deniffel D,
    2. Sauter A,
    3. Dangelmaier J, et al

    . Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation. Eur J Radiol 2019;111:6–13 doi:10.1016/j.ejrad.2018.12.015 pmid:30691666

    CrossRefPubMed